InnovAge Holding Corp (INNV) Stock Analysis
Verdict: WATCH (do not buy)
Regulatory recovery and revenue growth are overshadowed by a staggering -459% earnings miss and a valuation that exceeds profitable peers.
Investment score: 42/100
Analysis as of
Is InnovAge Holding Corp stock worth reviewing? The TradeMates thesis
InnovAge shows promising top-line recovery but remains fundamentally broken on the bottom line with alarming earnings volatility.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 45/100 (weight 15%)
- Technical Momentum: 60/100 (weight 15%)
- Earnings Quality: 20/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
InnovAge Holding Corp opportunities and risks
What speaks for INNV
- Path to Profitability by 2026
What speaks against INNV
- High Frequency of Extreme Earnings Misses
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| INNV | n/a | 1.3x | 279.2x | 20.7% | -2.3% | 3.2% |
| AGL | n/a | 0.3x | n/a | -2.7% | -6.4% | -4.0% |
| WGS | n/a | 4.0x | n/a | 68.3% | -17.6% | -1.6% |
| ADUS | 17.5x | 1.2x | 11.1x | 32.5% | 6.9% | 7.8% |
| AVAH | 6.4x | 0.7x | 10.1x | 32.7% | 10.4% | 8.1% |
| NEO | n/a | 0.4x | n/a | 42.1% | -13.3% | -1.8% |
| Peer median | n/a | 0.7x | n/a | 32.7% | -6.4% | -1.6% |
Frequently asked questions about InnovAge Holding Corp (INNV)
Is INNV stock a good investment?
The TradeMates model rates InnovAge Holding Corp as WATCH (do not buy) with an investment score of 42/100. InnovAge shows promising top-line recovery but remains fundamentally broken on the bottom line with alarming earnings volatility. This is algorithmic model output, not personal investment advice.
Is INNV stock a buy?
The TradeMates model verdict for INNV is WATCH (do not buy) with an investment score of 42/100. Treat this as a model signal to review, not a personal buy recommendation.